Cargando…

Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma

OBJECTIVE: This present study aimed to investigate the correlation of circular RNA SMARCA5 (circ‐SMARCA5) with clinicopathological features and overall survival (OS), and the effect of circ‐SMARCA5 on cell proliferation and chemotherapy sensitivity to cisplatin/gemcitabine in intrahepatic cholangioc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Qi, Fang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171308/ https://www.ncbi.nlm.nih.gov/pubmed/31880360 http://dx.doi.org/10.1002/jcla.23138

Ejemplares similares

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
por: Liu, Rui-qing, et al.
Publicado: (2013)

Effect of age on the prognosis of intrahepatic cholangiocarcinoma
por: Kim, Jung Hun, et al.
Publicado: (2023)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
por: Xu, Linping, et al.
Publicado: (2022)

Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
por: Massa, Annamaria, et al.
Publicado: (2022)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis
por: Sha, Meng, et al.
Publicado: (2018)

MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma
por: Ma, Xijuan, et al.
Publicado: (2020)

Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis
por: Tan, Zhenhua, et al.
Publicado: (2021)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
por: Sammon, Jennifer, et al.
Publicado: (2018)

The expression profiles of circular RNAs and competing endogenous RNA networks in intrahepatic cholangiocarcinoma
por: Liang, Zi, et al.
Publicado: (2022)

Retracted: Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection
por: Jeong, Seogsong, et al.
Publicado: (2017)

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion
por: Meng, Xian-Long, et al.
Publicado: (2022)

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
por: Garajová, Ingrid, et al.
Publicado: (2023)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
por: Fu, Kui, et al.
Publicado: (2020)

High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2021)

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
por: Garajová, Ingrid, et al.
Publicado: (2023)

Flotillin-2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma
por: Xu, Zhiying, et al.
Publicado: (2020)

A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case
por: Fu, Qiang, et al.
Publicado: (2022)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma
por: Chai, Xiaoqiang, et al.
Publicado: (2022)

Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
por: Peng, Jianbo, et al.
Publicado: (2023)

The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

NRBP2 Overexpression Inhibits Cell Proliferation and Migration and Increases Cisplatin Sensitivity in Intrahepatic Cholangiocarcinoma
por: Li, Xiaopeng, et al.
Publicado: (2017)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021)

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma
por: Guo, Kaibo, et al.
Publicado: (2023)

The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma
por: Wang, Jianping, et al.
Publicado: (2023)

A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients
por: Lv, Yinghao, et al.
Publicado: (2023)

Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?
por: Lin, Qianyi, et al.
Publicado: (2023)

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs
por: Yang, Renjie, et al.
Publicado: (2022)

A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
por: Kim, Gun Min, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f3vhh1rmk2rrebh9ln4pd8g3tl